Oculus Innovative Sciences, Inc. Share Price Nasdaq
Equities
US67575P2074
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
09/07 | Sonoma Pharmaceuticals, Inc. Announces New Distributor in Ukraine | CI |
17/06 | Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Sales 2025 * | 1.7Cr 141.9Cr | Sales 2026 * | 2.13Cr 178Cr | Capitalization | 81.11L 68Cr |
---|---|---|---|---|---|
Net income 2025 * | -30L -25Cr | Net income 2026 * | -10L -8.36Cr | EV / Sales 2025 * | 0.48 x |
Net cash position 2025 * | - 0 | Net cash position 2026 * | - 0 | EV / Sales 2026 * | 0.38 x |
P/E ratio 2025 * |
-2.13
x | P/E ratio 2026 * |
-4.74
x | Employees | - |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 97.88% |
Managers | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/19/27 |
John Poggetto
DFI | Director of Finance/CFO | 72 | 01/02/01 |
Jerome Dvonch
DFI | Director of Finance/CFO | 56 | 08/20/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/19/27 |
Jay Birnbaum
BRD | Director/Board Member | 79 | 20/07/20 |
Director/Board Member | 64 | 19/18/19 |
1st Jan change | Capi. | |
---|---|---|
+55.35% | 85TCr | |
+31.64% | 63TCr | |
-0.10% | 36TCr | |
+15.47% | 32TCr | |
+13.10% | 30TCr | |
+15.51% | 24TCr | |
+16.72% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |